| 000 | 01431 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515155221.0 | ||
| 264 | 0 | _c20090302 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1471-2334 | ||
| 024 | 7 |
_a10.1186/1471-2334-9-10 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShittu, Adebayo O | |
| 245 | 0 | 0 |
_aPhenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa. _h[electronic resource] |
| 260 |
_bBMC infectious diseases _cJan 2009 |
||
| 300 |
_a10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aHospitals _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aMupirocin _xpharmacology |
| 650 | 0 | 4 | _aNigeria |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aSouth Africa |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 700 | 1 | _aUdo, Edet E | |
| 700 | 1 | _aLin, Johnson | |
| 773 | 0 |
_tBMC infectious diseases _gvol. 9 _gp. 10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2334-9-10 _zAvailable from publisher's website |
| 999 |
_c18621981 _d18621981 |
||